TOWA PHARMACEUTICAL CO., LTD. produces generic drugs mainly for elderly.  The Company also wholesales medicine and medical products of other pharmaceuticals.

Consolidated Financial Results For The Six Months Ended September 30, 2024 (Based On Japanese Gaap)

Supplementary Material For The Financial Results For The Second Quarter (Interim Period) Of The Year Ending March 31, 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Towa Pharmaceutical (4553 JP)

Consolidated Financial Results For The Six Months Ended September 30, 2024 (Based On Japanese Gaap)

Supplementary Material For The Financial Results For The Second Quarter (Interim Period) Of The Year Ending March 31, 2025

Notice Of Revisions Of Financial Forecasts

Notice Of Settlement Of Lawsuit

Supplementary Material For The Financial Results For The First Quarter Of The Year Ending March 31, 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)